Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Summit Therapeutics PLC (SMMT) Gross Margin data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-62.91M |
|
-- |
|
-- |
|
$66.85M |
|
$-66.85M |
|
$3.94M |
|
$-62.91M |
|
$-62.91M |
|
$-62.91M |
|
$-62.91M |
|
$-62.91M |
|
$-62.91M |
|
$-66.85M |
|
$-66.83M |
|
738.08M |
|
738.08M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$370.75M |
|
$0.65M |
|
$13.07M |
|
$383.82M |
|
$34.88M |
|
-- |
|
$4.62M |
|
$39.49M |
|
$344.33M |
|
$342.41M |
|
$344.33M |
|
741.61M |
|
| Cash Flow Statement Financials | |
$-61.17M |
|
$160.11M |
|
$7.68M |
|
$105.19M |
|
$211.84M |
|
$106.66M |
|
$11.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-61.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.27% |
|
-18.37% |
|
-16.39% |
|
-18.27% |
|
$0.46 |
|
$-0.08 |
|
$-0.08 |
|